Company Quick10K Filing
HV Bancorp
10-Q 2021-03-31 Filed 2021-05-13
10-K 2020-12-31 Filed 2021-03-30
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-14
10-K 2019-06-30 Filed 2019-09-26
10-Q 2019-03-31 Filed 2019-05-14
10-Q 2018-12-31 Filed 2019-02-14
10-Q 2018-09-30 Filed 2018-11-14
10-K 2018-06-30 Filed 2018-09-27
10-Q 2018-03-31 Filed 2018-05-14
10-Q 2017-12-31 Filed 2018-02-13
10-Q 2017-09-30 Filed 2017-11-13
10-K 2017-06-30 Filed 2017-09-28
10-Q 2017-03-31 Filed 2017-05-12
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-12-22
8-K 2020-11-06
8-K 2020-08-19
8-K 2020-08-06
8-K 2020-05-20
8-K 2020-05-01
8-K 2020-02-28
8-K 2019-11-20
8-K 2019-11-18
8-K 2019-11-08
8-K 2019-08-21
8-K 2019-08-15
8-K 2019-07-17
8-K 2019-05-03
8-K 2019-04-17
8-K 2018-11-21
8-K 2018-08-17
8-K 2018-06-13
8-K 2018-05-16
8-K 2018-02-21
8-K 2018-02-21
8-K 2018-01-16

HV Bancorp Financials

HVBC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash11,96588,44547,55228,57715,60714,80214,94214,7456,02016,99212,88220,23427,255
Accounts Receivable
Inventory
PP&E1,6481,7341,7885,1461,8081,8341,8325,4221,9762,0292,1586,1812,338
Assets177,115239,140216,922216,765217,945242,656263,844297,762302,310320,883306,685344,195356,559
Accounts Payable
Long-Term Debt
Liabilities163,919226,193185,849185,324186,281210,943233,336267,041271,307289,472274,876311,515323,275
Stockholders' Equity13,19612,94731,07331,44131,66431,71330,50830,72131,00331,41131,80932,68033,284
Income Statement ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue7235304251
Cost of Revenue
Gross Profit
R&D
SG&A
Tax118-384174889424048884-24126101
Net Income253399817923617913222327013962408333
Cash Flow ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating77817,719513-6,2662,957-1,4013,969-1,37810,574-28,449-3,949
Cash Investing655-3,796-18,933-12,190-16,930-24,138-24,968-11,510-325-1895,433
Cash Financing-4,89562,557-22,473-5191,00324,73421,1394,163-14,35935,9905,537